← Evidence map

TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study.

James C Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

151 papers cite itlatest 60 shown

2016
…
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 27621394